Forecasting Consumption of Select Reproductive, Maternal, Newborn, and Child Health Medical Products

Increasing access to and appropriate use of reproductive, maternal, newborn, and child health (RMNCH) medical products could save the lives of more than 6 million women and children annually. A major component of access is availability, which requires accurate and timely quantification of supply requirements. Systematic and rigorous quantification of RMNCH medical products is often overlooked as the focus is more on donor-driven vertical programs such as HIV, TB, and malaria.

This forecasting supplement, which complements a general guidance document Quantification of Health Commodities: A Guide to Forecasting and Supply Planning for Procurement, will assist program managers, service providers, and technical experts when conducting quantification of needs for priority reproductive, maternal, newborn, and child health medical products. It has been updated to include new products and recommendations from WHO.